We are monitoring the impact of COVID-19 on Europe Stem Cell Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1024
Share on
Share on

Europe Stem Cell Market Research Report - Segmented By Mode Of Treatment, Applications, Technology, Type & By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1024
Pages: 140

Europe Stem Cell Market Size (2021 to 2026)

The European stem cell market is forecasted to grow from USD 3305.93 Million in 2021 and to USD 5774.34 million by the end of 2026, growing at a CAGR of 11.80% during the forecast period.

Stem cells are cells with the unique ability to create into a special type of cell in the body. These cells are used to replace the damaged cells because of any diseases. There are two types of stem cells in the human body, i.e., embryonic stem cells and induced pluripotent stem cells.

Regenerative medicine is perhaps the most important use of stem cells, and other essential areas include oncology, hematology, orthopedics, cardiology, and neurology. Another widely found application is drug discovery and development. Stem cells are a research tool, as their in vitro study would allow scientists to understand the role of various organs and the development of particular illnesses; stem cells may also enable drug developers to test emerging therapies on diseased cells. For example, stem cell therapy has shown a substantial potential to treat cancer successfully. Cancer stem cells that have been tested on animals have shown satisfactory results.

Some of the key drivers of the European stem cell market are improved funding from various government and private organizations for research and development for unmet medical needs, growing industry attention on stem cell research, and increasing global awareness about stem cell therapies. In addition, the development of cutting-edge genomic techniques for stem cell analysis and increasing approvals for clinical trials of stem cell therapy are other factors propelling the market's growth.

While on the other hand, ethical issues are involved in stem cell research, and strict regulations to conduct trials on humans are some restraining factors. Also, factors such as lack of required infrastructure and complications associated with the preservation of stem cells are limiting the growth of the stem cells market.

This research report on the European Stem Cell Market has been segmented and sub-segmented the Europe Stem Cell Market into the following categories:

By Treatment mode: 

  • Allogeneic
  • Autologous

By Cells Type: 

  • Adult Stem Cells
  • Induced Pluripotent Stem Cells
  • Human Embryonic Stem Cells
  • Others

By Technology: 

  • Cell Acquisition
  • Cell Production
  • Cryopreservation
  • Others

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regionally, the European region is always known as the hub of biotechnology research. Rising demand for research and development activities of drugs and vaccines is one of the significant factors accelerating the Europe Stem cell market growth. In addition, Europe has standard research quality with regenerative medicine, which solely boosts the market's growth rate. For example, TiGenix & Alofisel recently developed the first allogeneic stem cell therapy to treat luminal Crohn's disease and received approval for use in Europe.

During the forecast period, the UK stem cell market is predicted to dominate the European market. Increasing support from government bodies to promote quality services is elevating the market's demand in the UK.

The German stem cell market is expected to register healthy CAGR from 2021 to 2026. As per the German researcher, stem cell injections also cure type -2 diabetes, cardiovascular diseases, heredity eye disease, neurological disorders such as Parkinson's, Alzheimer's, and even cancer. In Germany, there is a center for regenerative medicine & stem cell therapy. The Centre provides treatment through cutting-edge technology & innovative medicine to cure the disease. Therefore, the adoption of the latest technologies is bolstering the growth rate of the market in Germany.  

The stem cell market in France is expected to be another lucrative regional market in Europe. A country like France is focusing on clinical trials. The researcher is studying the intravenous injection of autologous mesenchymal stem cells therapy to cure ischemic stroke. These strokes happen when a blood clot blocks the blood flow in the brain.

KEY MARKET PLAYERS:

A few of the prominent companies leading the Europe Stem Cell Market profiled in the report are Athersys, StemCells Inc, Cryo-Cell International, Geron Corporation, Mesoblast Ltd, Aastrom Biosciences Inc, Celgene Corporation, Invitrogen and Cytori Therapeutics Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By mode of treatment                           

                                5.1.1 Autologous             

                                5.1.2 Allogeneic

                5.2 By application                            

                                5.2.1 CNS            

                                5.2.2 CVS            

                                5.2.3 GIT             

                                5.2.4 Regenerative Medicine     

                                5.2.5 Musculoskeletal   

                                5.2.6 Eye & Immune System Development          

                                5.2.7 Blood Disorders    

                5.3 By technology                           

                                5.3.1 Cell Acquisition     

                                5.3.2 Cell Production     

                                5.3.3 Cryopreservation 

                                5.3.4 Expansion

                                5.3.5 Sub-Culture            

                5.4 By type                        

                                5.4.1 Adult Stem Cells   

                                5.4.2 Human Embryonic Cells     

                                5.4.3 Pluripotent Stem Cell          

                                5.4.4 Natural Rosette Cells          

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 U.K

                                6.3 Spain             

                                6.4 Germany     

                                6.5 Italy               

                                6.6 France          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Athersys                      

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 StemCells                    

                8.3 Cryo Cell International                           

                8.4 Geron Corporation                  

                8.5 Mesoblast                  

                8.6 Aastrom Biosciences                               

                8.7 Celgene Corporation                              

                8.8 Invitrogen                   

                8.9 Cytori Therapeutics                 

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

                                               

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Europe Stem Cells Market By mode of treatment, From 2021 to 2026 (USD Billion)                                                
  2. Europe Autologous Market By Region, From 2021 to 2026 (USD Billion)                                                    
  3. Europe Allogeneic Market By Region, From 2021 to 2026 (USD Billion)                                                      
  4. Europe Stem Cells Market By Application, From 2021 to 2026 (USD Billion)                                                             
  5. Europe CNS Market By Region, From 2021 to 2026 (USD Billion)                                                   
  6. Europe CVS Market By Region, From 2021 to 2026 (USD Billion)                                                   
  7. Europe GIT Market By Region, From 2021 to 2026 (USD Billion)                                                    
  8. Europe Regenerative Medicine Market By Region, From 2021 to 2026 (USD Billion)                                                             
  9. Europe Musculoskeletal Market By Region, From 2021 to 2026 (USD Billion)                                                          
  10. Europe Eye & Immune System Development Market By Region, From 2021 to 2026 (USD Billion)                                                  
  11. Europe Blood Disorders Market By Region, From 2021 to 2026 (USD Billion)                                                           
  12. Europe Stem Cells Market By Technology, From 2021 to 2026 (USD Billion)                                                             
  13. Europe Cell Acquisition Market By Region, From 2021 to 2026 (USD Billion)                                                             
  14. Europe Cell Production Market By Region, From 2021 to 2026 (USD Billion)                                                            
  15. Europe Cryopreservation Market By Region, From 2021 to 2026 (USD Billion)                                                         
  16. Europe Expansion Market By Region, From 2021 to 2026 (USD Billion)                                                      
  17. Europe Sub-Culture Market By Region, From 2021 to 2026 (USD Billion)                                                    
  18. Europe Stem Cells Market By type, From 2021 to 2026 (USD Billion)                                                           
  19. Europe Adult Stem Cells Market By Region, From 2021 to 2026 (USD Billion)                                                           
  20. Europe Human Embryonic Cells Market By Region, From 2021 to 2026 (USD Billion)                                                            
  21. Europe Pluripotent Stem Cell Market By Region, From 2021 to 2026 (USD Billion)                                                 
  22. Europe Natural Rosette Cells Market By Region, From 2021 to 2026 (USD Billion)                                                 
  23. U.K. Stem Cells Market By mode of treatment, From 2021 to 2026 (USD Billion)                                                     
  24. U.K. Stem Cells Market By Application, From 2021 to 2026 (USD Billion)                                                   
  25. U.K. Stem Cells Market By Technology, From 2021 to 2026 (USD Billion)                                                    
  26. U.K. Stem Cells Market By type, From 2021 to 2026 (USD Billion)                                                 
  27. Germany Stem Cells Market By mode of treatment, From 2021 to 2026 (USD Billion)                                                         
  28. Germany Stem Cells Market By Application, From 2021 to 2026 (USD Billion)                                                         
  29. Germany Stem Cells Market By Technology, From 2021 to 2026 (USD Billion)                                                         
  30. Germany Stem Cells Market By type, From 2021 to 2026 (USD Billion)                                                       
  31. France Stem Cells Market By mode of treatment, From 2021 to 2026 (USD Billion)                                              
  32. France Stem Cells Market By Application, From 2021 to 2026 (USD Billion)                                              
  33. France Stem Cells Market By Technology, From 2021 to 2026 (USD Billion)                                                              
  34. France Stem Cells Market By type, From 2021 to 2026 (USD Billion)                                                            
  35. Italy Stem Cells Market By mode of treatment, From 2021 to 2026 (USD Billion)                                                   
  36. Italy Stem Cells Market By Application, From 2021 to 2026 (USD Billion)                                                   
  37. Italy Stem Cells Market By Technology, From 2021 to 2026 (USD Billion)                                                   
  38. Italy Stem Cells Market By type, From 2021 to 2026 (USD Billion)                                                
  39. Spain Stem Cells Market By mode of treatment, From 2021 to 2026 (USD Billion)                                                 
  40. Spain Stem Cells Market By Application, From 2021 to 2026 (USD Billion)                                                
  41. Spain Stem Cells Market By Technology, From 2021 to 2026 (USD Billion)                                                
  42. Spain Stem Cells Market By type, From 2021 to 2026 (USD Billion)                                              

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample